A detailed history of Ameriprise Financial Inc transactions in Novartis Ag stock. As of the latest transaction made, Ameriprise Financial Inc holds 424,828 shares of NVS stock, worth $44.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
424,828
Previous 447,674 5.1%
Holding current value
$44.3 Million
Previous $47.7 Million 2.53%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $2.42 Million - $2.76 Million
-22,846 Reduced 5.1%
424,828 $48.9 Million
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $1.68 Million - $1.95 Million
18,132 Added 4.22%
447,674 $47.7 Million
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $6.18 Million - $7.03 Million
64,829 Added 17.78%
429,542 $41.5 Million
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $1.14 Million - $1.25 Million
-12,336 Reduced 3.27%
364,713 $36.8 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $4.39 Million - $4.87 Million
-46,338 Reduced 10.94%
377,049 $38.4 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $891,152 - $1.01 Million
9,632 Added 2.33%
423,387 $42.7 Million
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $12.4 Million - $14.3 Million
-154,542 Reduced 27.19%
413,755 $38.1 Million
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $5.77 Million - $7.07 Million
-76,390 Reduced 11.85%
568,297 $51.6 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $4.93 Million - $5.77 Million
-66,093 Reduced 9.3%
644,687 $49 Million
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $61.7 Million - $71.8 Million
-766,267 Reduced 51.88%
710,780 $60.1 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $10.3 Million - $11.7 Million
129,010 Added 9.57%
1,477,047 $130 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $5.34 Million - $5.9 Million
-66,951 Reduced 4.73%
1,348,037 $118 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $25.7 Million - $29.9 Million
-313,799 Reduced 18.15%
1,414,988 $116 Million
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $308,483 - $340,728
3,619 Added 0.21%
1,728,787 $158 Million
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $2.34 Million - $2.76 Million
-27,982 Reduced 1.6%
1,725,168 $147 Million
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $49.8 Million - $60.2 Million
637,848 Added 57.19%
1,753,150 $166 Million
Q3 2020

Nov 16, 2020

SELL
$82.14 - $91.0 $4.4 Million - $4.87 Million
-53,513 Reduced 4.58%
1,115,302 $97.1 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $3.08 Million - $3.46 Million
-38,000 Reduced 3.15%
1,168,815 $102 Million
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $251,514 - $352,376
-3,559 Reduced 0.29%
1,206,815 $99.4 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $15.5 Million - $17.5 Million
183,560 Added 17.88%
1,210,374 $115 Million
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $2.42 Million - $2.67 Million
-28,301 Reduced 2.68%
1,026,814 $89.2 Million
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $207,274 - $255,107
-2,749 Reduced 0.26%
1,055,115 $96.3 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $841,399 - $962,381
11,171 Added 1.07%
1,057,864 $102 Million
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $4.87 Million - $5.42 Million
66,100 Added 6.74%
1,046,693 $89.8 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $3.52 Million - $4.07 Million
52,616 Added 5.67%
980,593 $106 Million
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $1.53 Million - $1.73 Million
23,578 Added 2.61%
927,977 $70.1 Million
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $3.78 Million - $4.52 Million
-53,707 Reduced 5.61%
904,399 $73.2 Million
Q4 2017

Feb 12, 2018

SELL
$72.33 - $77.64 $1.59 Million - $1.71 Million
-22,017 Reduced 2.25%
958,106 $80.4 Million
Q3 2017

Nov 07, 2017

BUY
$74.14 - $77.27 $72.7 Million - $75.7 Million
980,123
980,123 $84.1 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.